Liver Injury clinical trials at UCSF
1 research study open to eligible people
Liver injury occurs when the liver is damaged and loses its ability to function. UCSF is running trials to explore the effects of immune-suppressing therapies on liver damage in children. These trials aim to determine the best treatment options.
TReatment for ImmUne Mediated PathopHysiology
open to eligible people ages 1-18
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticosteroids or equine anti-thymocyte globulin therapy improves survival for children with this rare, life-threatening condition.
San Francisco, California and other locations
Last updated: